Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
New patent underscores breadth of application and expansion opportunities for Company's catheter-based technology
Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications
THE WOODLANDS, TX, April 16, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ('Autonomix' or the 'Company'), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that European Patent Office (EPO) has granted Patent No. 3,226,792 (the '792) titled, ' Systems And Methods For Regulating Organ and/or Tumor Growth Rates, Function, and/or Development.' The granted '792 patent relates to the field of neuromodulation and covers a range of methods and systems used in nerve and receptor monitoring, electrophysiological monitoring, and surgical procedures related to the systems and mechanisms that regulate prostate and tumor growth.
'With the potential to address a wide range of conditions in which nerve activity plays a central role, we remain committed to strengthening our patent portfolio to support future applications and expansion opportunities. This European patent further validates the broad applicability of our technology across multiple conditions and anatomical targets. While our focus is on advancing development to reduce pancreatic cancer pain by targeting the celiac plexus, we believe our novel approach has the potential to address a broad array of peripheral nerve bundles associated with pain,' commented Brad Hauser, CEO of Autonomix.
In particular, the methods and systems covered in the '792 patent may be used to sense, ablate and verify neurological traffic to and from the prostate and organs of the lower urinary tract (LUT) in order to slow, halt and/or reverse the growth of a prostate gland or a prostate tumor. Beyond prostate-related treatments, these systems and methods have potential applications in addressing various LUT diseases that share physiology of the prostatic plexus, including chronic prostatitis, hypogonadism, nocturia, and erectile dysfunction, by modulating neural activity and hormonal secretions of related organs.
The Company is currently advancing its plans to submit an IDE and commence U.S. clinical trials in 2025 to support a labeling indication to commercialize the Autonomix Sensing and RF Ablation System in the U.S. as a treatment for pancreatic cancer pain.
For more information about the Company's technology, please visit autonomix.com.
About Autonomix Medical, Inc.
Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.
We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.
Forward Looking Statements
Some of the statements in this release are 'forward-looking statements,' which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the potential of the technology to treat cancerous tumors and the pain associated with pancreatic cancer. Such forward-looking statements can be identified by the use of words such as 'should,' 'might,' 'may,' 'intends,' 'anticipates,' 'believes,' 'estimates,' 'projects,' 'forecasts,' 'expects,' 'plans,' and 'proposes.'
Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading 'Risk Factors' and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on May 31, 2024. Forward-looking statements speak only as of the date of the document in which they are contained and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.
Investor and Media Contact
JTC Team, LLC
Jenene Thomas
908.824.0775
[email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Jim Cramer Highlights That Dollar Tree (DLTR) Has 'More Trouble With the Tariffs'
We recently published a list of . In this article, we are going to take a look at where Dollar Tree, Inc. (NASDAQ:DLTR) stands against other stocks that Jim Cramer discusses. Discussing the impact of tariffs on Dollar Tree, Inc. (NASDAQ:DLTR), Cramer stated: 'Discount retailers tend to do better when the consumers' feeling stretched thin, and you know the consumer's feeling that way. But Dollar General and Dollar Tree have behaved very differently after reporting earnings over the past couple days… Then today, Dollar Tree reported what I also thought was a pretty good quarter, but its stock got eviscerated, down 8%. What explains the disparity here?… The difference between these two comes down to what they had to say about their ability to control costs and offset the impact of, you bet, go ahead, the president's tariffs… A shopper browsing through a discount retailers merchandise aisle filled with a wide variety of items. Dollar Tree (NASDAQ:DLTR) runs discount retail stores that carry a wide variety of products. The selection includes consumables, home essentials, seasonal items, apparel, and electronics. Overall, DLTR ranks 8th on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of DLTR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Ampere Analysis Breaks Down The Threat U.S. Tariffs Would Pose To European Film & TV
Speaking at NEM in Croatia, Ampere Analysis Co-Founder Guy Bisson ran the rule over the so-called plan to save Hollywood from Jon Voight and associates, and assessed the potential impact on the European film and TV biz. 'A 120% tariff on incentives to cancel out global schemes is patently ridiculous and obviously very damaging, potentially, to the European industry,' he said. 'Tax treaties, local tax treaties in the U.S., and incentive schemes, just like we use in Europe, clearly, are the way to go if you want to re-enliven your industries.' More from Deadline Donald Trump's Tariffs Deemed Unlawful & Blocked By Trade Court; White House Appeals Instantly Life After Peak TV: "It's A New World Order... There's A Rethink Required" - Berlin Streamer Content Spend To Top Commercial Broadcasters For First Time In 2025 - Report A draft of Voight's Make Hollywood Great Again plan, obtained by Deadline, included a mixture of production incentives and a 120% tariff on the value of a foreign incentive received. After he presented the plan to Donald Trump, the President public proposed a 100% tariff on all U.S. film imports, including productions that shoot in other countries. The NEM confab and sales market is held annually in Dubrovnik. The latest edition kicked off, Monday, with Bisson's session, which was entitled: 'Content Trends in the Era of Trump: Protectionism, Production and International Markets'. The Ampere executive set the scene by showing how the European content business has benefitted from the U.S. studios widening their production bases and streamers setting up shop in several parts of the continent, resulting in orders for thousands of hours of first-run programming. He also said international markets are key to those same U.S. giants monetizing their series and movies with, for example, 54% of the total box office for U.S. films coming from international markets, according to Ampere. Getting into the weeds on the suggested measures, he said a 120% tariff on any incentive received overseas is 'one of the most concerning aspects of the proposal, effectively closing the door on U.S. producers making use of any overseas incentive.' He went on to break down what might happen if the proposed measure were introduced with a slide that pinpointed the UK and Spain as the two biggest potential losers in Europe, given the volumes of U.S. production in both countries. 'Obviously the big European markets – the UK, France, Italy, Spain, Germany – are on that list, but so is Poland, for example, and Turkey, and the Scandinavian markets. They have been the [among] biggest beneficiaries of that 'runaway' production.' Speaking about the notion of tax treaties with certain countries for films substantially produced in U.S., Bisson said the idea is interesting: 'While you still have to make a majority, or spend a majority of the budget, in the U.S., you can effectively stack or double dip incentive schemes through those treaties.' He also said any re-introduction of rules that prohibit networks (and now, SVODs) fully owning shows 'would remove one of the things that's annoyed producers so much, which is streamers taking all rights in perpetuity.' Trump has said that he would meet with industry officials, and the White House said no final decisions have been made regarding the plan. Voight, Sylvester Stallone and a group that included studios and unions later wrote a letter to Trump emphasizing the need for production incentives While punchy, the NEM presentation was, thusly, analyzing what are currently theoretical scenarios. Bisson said that the best hope for the European biz is that theory never becomes practice. 'None of this is actually happening or being put in place yet, it's just a suggestion,' he said. 'Who can predict what Trump will do next. You may have heard the nickname that Trump has been given: TACO; Trump, Always Chickens Out on tariffs. That's what we can hope will happen again when it comes to our industry and the suggested protectionism being placed on film and TV.' Ted Johnson contributed to this report. Best of Deadline 2025 TV Series Renewals: Photo Gallery Tony Awards: Every Best Musical Winner Since 1949 Tony Awards: Every Best Play Winner Since 1947
Yahoo
12 minutes ago
- Yahoo
Sedalia announces end of Hot Air Balloon and Kite Festival
KANSAS CITY, Mo. — The Sedalia Chamber of Commerce made an unexpected announcement Friday, confirming the end of a popular event that attracted visitors from all over the state. According to a , the city will no longer be hosting the Hot Air Balloon and Kite Festival, which has been held in June for the past two years. 'World's Largest Rubber Duck' coming to Missouri State Fair 'We are so incredibly thankful for the generous support from our sponsors and the amazing community turnout over the past two years for the Hot Air Balloon and Kite Festival. It has been such a joy to see our community come together and make lasting memories at this special event,' the chamber of commerce said. The post said the event was canceled due to staffing limitations and a lack of resources. 'This was not an easy decision, and we truly appreciate your understanding and continued support and we focus on other ways to serve and celebrate our community,' the chamber said on Facebook. Despite this popular event ending, the city has a number of other events planned throughout the year. . Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
